Cited by

• Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum.

  Ljungman P, Chemaly RF, Khawaya F, Alain S, Avery R, Badshah C, Boeckh M, Fournier M, Hodowanec A, Komatsu T, Limaye AP, Manuel O, Natori Y, Navarro D, Pikis A, Razonable RR, Westman G, Miller V, Griffiths PD, Kotton CN; CMV Definitions Working Group of the Transplant Associated Virus Infections Forum. Ljungman P, et al. Clin Infect Dis. 2024 Sep 26;79(3):787-794. doi: 10.1093/cid/ciae321. Clin Infect Dis. 2024. PMID: 39041385 Free PMC article.
• Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.

  Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, Kotton C, Lundgren J, Komatsu TE, Lischka P, Josephson F, Douglas CM, Umeh O, Miller V, Ljungman P; Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum. Chemaly RF, et al. Clin Infect Dis. 2019 Apr 8;68(8):1420-1426. doi: 10.1093/cid/ciy696. Clin Infect Dis. 2019. PMID: 30137245 Free PMC article.
• Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.

  Patel YA, Imperial JC, Muir AJ, Anstee QM, DeBrota D, Dimick-Santos L, Filozof C, Mehta R, Sanyal AJ, Schabel E, Neuschwander-Tetri BA, Miller V; Liver Forum’s Data Standardization Working Group. Patel YA, et al. Gastroenterology. 2017 Sep;153(3):621-625.e7. doi: 10.1053/j.gastro.2017.07.024. Epub 2017 Jul 27. Gastroenterology. 2017. PMID: 28757264 Free PMC article. No abstract available.
• Novel clinical trial designs for the development of new antiretroviral agents.

  Mani N, Murray J, Gulick RM, Josephson F, Miller V, Miele P, Strobos J, Struble K. Mani N, et al. AIDS. 2012 May 15;26(8):899-907. doi: 10.1097/QAD.0b013e3283519371. AIDS. 2012. PMID: 22301412 Free PMC article. Review.
• Stakeholder engagement to inform HIV clinical trials: a systematic review of the evidence.

  Day S, Blumberg M, Vu T, Zhao Y, Rennie S, Tucker JD. Day S, et al. J Int AIDS Soc. 2018 Oct;21 Suppl 7(Suppl Suppl 7):e25174. doi: 10.1002/jia2.25174. J Int AIDS Soc. 2018. PMID: 30334358 Free PMC article.